BN · rank #13 · 2026-10-20
EXENS
PARIS · EUR · $3.36B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of the factors below; drives the rank. | -0.35 |
|---|---|
| Forward revenue growth Consensus forward revenue growth. | +13.2% |
| Forward net margin Consensus forward net margin. | +6.6% |
| Net margin TTM Trailing twelve month net margin. | +6.0% |
| Margin expansion Forward minus trailing net margin (percentage points). | +0.6% |
| Forward PEG Forward P/E to growth. Below 1 is cheap for the growth. | — |
| Debt / FCF Net debt relative to free cash flow. Lower is safer. | 2.58× |
| Analyst upside Spread between the consensus 12m target and the current price. | +17.9% |
| Last EPS surprise Most recent reported EPS versus consensus. | — |
| Market cap (USD) | $3.36B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Exosens develops and manufactures high-performance image-intensifier tubes, thermal cameras, cooled infrared sensors, and nuclear instrumentation for defense, surveillance, and industrial applications.
Rationale
Exosens operates as the sole ITAR-free European supplier of 5G image-intensifier tubes for NATO defense, supporting the bottleneck-solver thesis alongside upgraded FY2026 guidance and multi-year contract visibility.
Material risks
- 1Major defense system integrators could dual-source or develop in-house infrared and night-vision capabilities, eliminating Exosens's single-source component bottleneck.
- 2Execution risks in tripling thermal-camera and doubling cooled-infrared capacity during 2026, alongside short-term volatility around the October 27 earnings report.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.